The World Health Organization (WHO) said Saturday that it suspended studies evaluating AbbVie’s hydroxychloroquine and ABBV, + 0.56% HIV medicine Kaletra as possible treatments for COVID-19. The WHO has conducted a multiple clinical trial testing a handful of potential treatments in hospitalized patients with COVID-19 since late March. “These interim …
Read More »WHO formally eliminates hydroxychloroquine, HIV drug from drug study COVID-19
